The United Laboratories International Holdings Limited (SEHK:3933) commences share repurchases on December 13, 2021, under the program mandated by the shareholders in the Annual General Meeting held on June 22, 2021. As per the mandate, the company is authorized to repurchase up to 184,039,050 shares, representing 10% of its issued share capital. The repurchases will lead to an enhancement of the net asset value per share and/or earnings per share for the company. The repurchases will be made out of the funds legally available for such purpose in accordance with its memorandum of association and Bye-laws and the applicable laws and regulations of Cayman Islands. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of June 22, 2021, the company had 1,840,390,508 shares in issue. On November 30, 2021, the company announced a share repurchase program. Under the program, the company will repurchase HKD 50 million worth of shares. The company will subsequently cancel the bought shares. The program will be financed by internal cash. The purpose of the program is to enhance the value of the shares and improve return to the shareholders.